SELLAS Life Sciences Group, Inc. Increase (Decrease) in Insurance Settlements Receivable
SELLAS Life Sciences Group, Inc. (SLS) reported Increase (Decrease) in Insurance Settlements Receivable of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInsuranceSettlementsReceivable · last filed 2019-11-14
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for the quarter ending 2017-09-30 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for the quarter ending 2017-06-30 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for the quarter ending 2017-03-31 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for fiscal 2016 was -$21.70M, a 200.00% decline from fiscal 2015.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for fiscal 2015 was $21.70M.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for fiscal 2014 was $0.00.
- SELLAS Life Sciences Group, Inc. increase (decrease) in insurance settlements receivable for fiscal 2013 was $0.00.
| Period end | Increase (Decrease) in Insurance Settlements Receivable 3 month | Increase (Decrease) in Insurance Settlements Receivable 6 month | Increase (Decrease) in Insurance Settlements Receivable 9 month | Increase (Decrease) in Insurance Settlements Receivable 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | |||
| 2018-09-30 | $474.00K 10-Q · filed 2019-11-14 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-11-09 | -$1.70M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | -$1.70M derived: sum of 3 quarters · filed 2017-11-09 | -$21.70M 10-K · filed 2017-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$1.70M derived: sum of 2 quarters · filed 2017-11-09 | -$21.70M 10-Q · filed 2017-11-09 | $0.00 derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$21.70M 10-Q · filed 2017-08-14 | $0.00 derived: sum of 3 quarters · filed 2017-08-14 | $0.00 derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$20.00M 10-Q · filed 2017-05-10 | $1.70M derived: sum of 2 quarters · filed 2017-05-10 | $1.70M derived: sum of 3 quarters · filed 2017-05-10 | $1.70M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $21.70M derived: sum of 2 quarters · filed 2017-03-15 | $21.70M derived: sum of 3 quarters · filed 2017-03-15 | $21.70M 10-K · filed 2017-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2013-12-31 | $0.00 10-K/A · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |